Cargando…
Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment
Hepatocellular carcinoma (HCC) exerts huge effects on the health burden of the world because of its high mortality and poor prognosis. HCC is often clinically detected late in patients. If HCC could be detected and treated earlier, the survival rate of patients will be greatly improved. Therefore, i...
Autores principales: | Xing, Mengtao, Wang, Xinzhi, Kiken, Robert A., He, Ling, Zhang, Jian-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201127/ https://www.ncbi.nlm.nih.gov/pubmed/34200243 http://dx.doi.org/10.3390/ijms22116139 |
Ejemplares similares
-
Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
por: Dai, Liping, et al.
Publicado: (2013) -
MRI in detection of hepatocellular carcinoma (HCC)
por: Digumarthy, Subba R, et al.
Publicado: (2005) -
Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011) -
Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020) -
Immunodiagnostic tests for Lyme disease.
por: Wilkinson, H. W.
Publicado: (1984)